[TARS] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[TARS] Tarsus Pharmaceuticals, Inc.
Announcement Date
11-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -36.27%
YoY- -295.05%
Quarter Report
TARS's Result
TARS's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 10,000 0 15,277 539 338 1,240 22,017 -40.82%
PBT -13,599 -22,516 -5,743 -20,237 -14,797 -16,038 6,374 -
Tax -521 -5 519 1 54 -341 29 -
NP -13,078 -22,511 -6,262 -20,238 -14,851 -15,697 6,345 -
Tax Rate - - - - - - -0.45% -
Total Cost 23,078 22,511 21,539 20,777 15,189 16,937 15,672 29.34%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -130.78 0.00 -40.99 -3,754.73 -4,393.79 -1,265.89 28.82 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.49 -0.84 -0.26 -0.98 -0.72 -0.76 0.31 -
EPS Diluted -0.49 -0.84 -0.26 -0.98 -0.72 -0.76 0.29 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.